The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the developmentoftheseevidence-basedguidelinesonthemanagementofCVSinadults, whichwassponsoredbytheAmericanNeurogastroenterologyandMotilitySociety (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was usedandaprofessionallibrarianperformedtheliteraturesearch.Theexpertcom-mitteeincludedthePresidentoftheCVSAwhobroughtapatientperspectiveinto the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committeestronglyrecommendsthatadultswithmoderate-to-severeCVSreceive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications.Zonisamideorlevetiracetamandmitochondrialsupplements(CoenzymeQ10, L-carnitine,andriboflavin)areconditionallyrecommendedasalternateprophylactic medications,eitheraloneorconcurrentlywithotherprophylacticmedications.For acuteattacks,thecommitteeconditionallyrecommendsusingserotoninantagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualizedtreatmentprotocolandsharedwiththecareteam(exampleprovided).
| INTRODUC TI ON
Cyclic vomiting syndrome (CVS) is a chronic functional gastrointestinal disorder that is being increasingly recognized in adults. 1, 2 It is characterized by episodic nausea and vomiting and is associated with significant morbidity. Approximately one-third of adult patients become disabled. 3 The committee members, who were selected jointly by the CVSA and a council member of the ANMS clinical guidelines committee, included primarily gastroenterologists with clinical and research expertise, providers from other disciplines, such as psychology and neurology, methodologists with experience in evidence appraisal andguidelinedevelopment,andonepatientrepresentative,whowas alsoPresidentoftheCVSA.Thepanelchairwasagastroenterologist.
Conflicts of interest of all participants were managed according to
ANMSpolicies.Atthetimeofappointment,amajorityoftheguidelinepanel,includingthechairandthevice-chair,hadnoconflictsof interest as defined and judged by ANMS policies. This manuscript was prepared by committee members and a patient advocate who served as part of the committee in order to incorporate patient valuesandpreferenceswhiledevelopingrecommendations,asperthe GRADE methodology. 6 A librarian conducted the literature search and two GRADE experts reviewed and graded the literature. The reader is referred to the accompanying technical review for a more detailed understanding of the process and additional details about individualstudies.Thecommittee hadfourin-personmeetings and multiple conference calls during this process. Committee members except for the two GRADE experts voted on all recommendations and either "agreed" or "disagreed" and votes were tallied.
Recommendations for the diagnosis of CVS, suggested investigations,treatmentprotocolfortheemergencydepartment(ED),and algorithm for management are also provided. These recommendations are based on best practices and consensus of the committee members.
These were formulated based on review of the available literature and thecollectiveexperienceofthecommitteememberswhohavetaken care of more than 3000 patients with CVS in their practices.
With increasing attention paid to use of cannabis in CVS, Cannabinoid Hyperemesis Syndrome (CHS) has been proposed as a distinctentitybytheRomeFoundation. 7-10 CHS,theroleofcannabisinhyperemesis,andtheoverlapbetweenCHSandCVSaredescribed in a separate manuscript included with these CVS guidelines.
| TRE ATMENT OF C YCLI C VOMITING SYNDROME
TreatmentofCVSshouldbebasedonabiopsychosocialcaremodel, integrating lifestyle modification, prophylactic and/or abortive medications, and evidenced-based psychotherapy to address psychiatric comorbidity. Ongoing care by a dedicated team will likely improve overall healthcare outcomes. Given the lack of validated outcomes to assess the severity of CVS, the committee arbitrarilydefinedseverityasmild,moderate,orseverebasedonthefrequencyanddurationofepisodes,needforhealthcareutilization,and impact of symptoms on activities of daily living as shown in shown in Table 1 .
Key Points
• These Evidence-Based Guidelines on the Management of CVS in Adults are based on the GRADE (Grading of ecommendations, Assessment, Development and Evaluation) framework and recommendations for the prophylaxisofCVS,treatmentofacuteattacks,diagnosis and overall management of CVS are made.
• The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA) such as amitriptyline, as a first-line prophylactic medication. For acute attacks, the committee conditionally recommends using serotonin antagonistssuchasondansetron,and/ortriptanssuchas sumatriptan or newer agents such as aprepitant (NK1 receptor antagonist) to abort symptoms.
• An individualized treatment plan for treatment of CVS in the emergency department can facilitate care and an exampleisprovided. Themeaneffectivedoseinadultsis75-100mgdailyor1-1.5mg/ kg body weight. 3, 15, 28 Amitriptyline is best titrated in 10-25 mg increments as this improves tolerability by allowing adaptation to and preventingdiscontinuationfromsideeffects,particularlydaytimesedation. This improves the ultimate efficacy of the medication. Most of the panelists used 10 mg but some used 25 mg. As always, this needs to be individualized based upon the patient response. The in-cidenceofsideeffectswithATvariesfrom9%to25%althoughthis did not result in discontinuation of the drug in most studies. 19 with amitriptyline but are not reported in CVS, perhaps due to the higher doses typically used to treat the former. 29 The evidence was considered very low quality despite the fact that there were 14 studies, given issues with selection bias, con- 
| PROPHYL AC TI C MED I C ATI ON S IN C VS

| Recommendation 1. We strongly recommend that adults with moderate-to-severe CVS receive tricyclic antidepressants (TCAs), especially amitriptyline, as a first-line prophylactic medication
| Recommendation 2. We conditionally recommend that adults with moderate-tosevere CVS receive topiramate as an alternate prophylactic medication
Grade: Conditional recommendation, very low-quality evidence. Vote:
100% agreement
Topiramate may be used as an alternative prophylactic medicationinmoderate-to-severeCVS.Severalstudiesshowthattopiramate is effective in preventing migraine headaches, but there is limited evidence on its utility in CVS. One retrospective study of 16 children treated with topiramate found that 81% became episodefree,13%showedatleast≥50%reductioninnumberof TA B L E 1 Recommendations for treatment of cyclic vomiting syndrome 1.
Westronglyrecommendthatadultswithmoderate-to-severeCVSreceivetricyclicantidepressants(TCAs)suchasamitriptyline,asa first-lineprophylacticmedication(verylow-qualityevidence)
2.
Weconditionallyrecommendthatadultswithmoderate-to-severeCVSreceivetopiramateasanalternateprophylacticmedication (verylow-qualityevidence)
3.
Weconditionallyrecommendthatadultswithmoderate-to-severeCVSreceiveaprepitantasanalternateprophylacticmedication (verylow-qualityevidence)
4.
Weconditionallyrecommendthatadultswithmoderate-to-severeCVSreceivezonisamideorlevetiracetamasanalternateprophylacticmedication(verylow-qualityevidence)
5.
WeconditionallyrecommendusingCo-Q10,andriboflavinasprophylactictherapyinthetreatmentofCVS.Mitochondrialsupplementsmaybeusedconcurrentlyinadditiontootherprophylacticagents(verylow-qualityevidence)
6.
WeconditionallyrecommendusingtriptanslikesumatriptantoabortsymptomsofaCVSepisode.(moderate-qualityevidence)
7.
We conditionally recommend using serotonin antagonists such as ondansetron to abort symptoms of a CVS episode (consensus statement)
8.
WeconditionallyrecommendaprepitanttoabortsymptomsofaCVSepisode(verylow-qualityevidence)
9.
Wesuggestscreeningandtreatmentforcomorbidconditionssuchasanxiety,depression,migraineheadache,sleepdisorders,autonomicdysfunction,andsubstanceuse.Wesuggestreferraltoappropriatealliedhealthservices(psychologist,psychiatrist,neurologist,sleep,orsubstanceusespecialist)asindicated(consensusstatement)
10.
Wesuggestthattechniquessuchasmeditation,relaxationandbiofeedbackbeofferedascomplementarytherapyinCVS.These measuresaregenerallydevoidofsideeffectsandmayimproveoverallwell-beingandpatientcareoutcomes(consensusstatement)
Recommendationsarelabeledaseither"strong"or"conditional"accordingtotheGRADEapproach.Cliniciansmayinterpret"strong"recommendations to mean that most individuals should receive the intervention. Clinicians may interpret "conditional" recommendations to mean that different choiceswillbeappropriateforindividualpatients,andcliniciansmusthelpeachpatientarriveatamanagementdecisionconsistentwiththepatient's valuesandpreferences.ConsensusstatementswerenotbasedontheGRADEapproachandwererecommendationsmadebythecommitteebased onindirectevidenceand/ortheircollectiveexperienceinmanagingadultandpediatricCVSpatients. episodes,andonly6%didnotrespond. 30 In a retrospective study of18adultstreatedwithprophylactictopiramate,72%had≥50% reduction in frequency/severity of CVS episodes. Some patients on topiramate were also receiving AT and mitochondrial supplements in this study. 3 We recommend starting topiramate at 25 mg daily and titrating 
| Recommendation 3. We conditionally recommend that adults with moderate-tosevere CVS receive aprepitant as an alternate prophylactic medication
| Recommendation 4. We conditionally recommend that adults with moderate-to-severe CVS receive zonisamide or levetiracetam as an alternate prophylactic medication
100% agreement
Zonisamide is an oral sulfonamide anti-epileptic (AED) with direct influence on sodium and calcium channel function as well as modulation of GABAergic receptors. 47, 48 It has high bioavailability withafairlylonghalf-life(~60hours)andismetabolizedintheliver by CYP3A4 enzymes before renal excretion. 48 In one non-placebo-controlled study of 11 children with CVS, the efficacy of sumatriptan treatment was high in those with a family history of migraine compared to cases without a family history of migraine. 64 However,thosewithoutafamilyhistoryofmigrainestill responded to sumatriptan in 50% of their attacks. In this study, sumatriptan was administered by SC injection in nine and via nasal route inthreepatients.Althoughthenumberofpatientswassmall,theadministration of sumatriptan reduced vomiting in nine patients (82%) and the nasal route seemed less effective. Three other case reports describe the efficacy of injectable sumatriptan in aborting episodes of CVS. 65 The committee believes that sumatriptan is effective in the acutetreatmentofCVSalthoughrandomizedplacebo-controlledstud-iesinvestigatingtheefficacyofsumatriptaninCVSattacksarelacking.
We recommend administration of triptans during the prodrome orwithin30-45minutesoftheonsetofvomitinginanepisode.The efficacy appears to diminish after the first 60 minutes. We recommend nasal and injectable administration given uncertain oral ab-sorptioninCVS.Forthenasalroute,werecommendadministering thedrug,whiletheheadisgentlyflexedforwardtoavoidnasopharyngeal dripping of the drug which can have a bitter taste. 66 We rec- 
| Recommendation 8. We conditionally recommend aprepitant to abort symptoms of a CVS episode
>80% agreement
There is a single open-label trial of oral aprepitant used as abortive treatment of CVS in children and adolescents who were refractory to conventional treatment. 43 All children >20 kg were given the standard regimen used in chemotherapy-induced nauseaand vomiting (CINV)of125mginitially during theprodrome, Migraine headache (including a family history of migraine) is closely linkedwith CVS. 4, 5 The prevalence of migraine headaches in adultswithCVSvariesbetween13%and70%. 15 Widespread drug usage has been found in CVS with 39%-81% usingcannabis,19%alcohol,36%tobacco,and17%reliantonnarcotics for pain management. 85, 86 Although none of these studies containedaspecificcomparisongroup,mostofthesefiguresappear tobehigherthanthosefoundinthegeneralpopulation.Co-occurring substance use or abuse can interact with medications for the managementofCVSandcomplicatetreatment,andthus,standard screening for such disorders and appropriate treatment is indicated.
| TRE ATMENT OF COMORB ID CONDITIONS
The role of cannabis in CVS and CHS is discussed in detail in a separate paper in this supplement.
| Recommendation 10. We suggest that techniques such as meditation, relaxation and biofeedback be offered as complementary therapy in CVS. These measures are generally devoid of side effects and may improve overall well-being and patient care outcomes
Vote: 100% agreement
Cyclic vomiting syndrome is a functional GI disorder that is thought to be due to altered brain-gut interaction. 87 The recommendations provided are summarized in Table 1 and aredrawnfromasystematicGRADEevaluationoftheliterature(1-6 and 8) and expert committee consensus (7,9 and 10) . We provide theserecommendationswithanappreciationofthelimited,andlowquality evidence provided from the literature aiming to bridge the gapbetweenwhatweknowandhowwecanbesthelppatientsat the present time.
| Consensus statement on diagnosis and management of CVS
The following section addresses the diagnosis, appropriate inves- 
| Diagnosis
Cyclic vomiting syndrome has typical clinical features, and the hallmarkofCVSisthepresenceofintermittentepisodesofsevere nausea and vomiting interspersed with symptom-free intervals.
However,patientsmayexperienceinter-episodicnauseaordyspepsia and may not be completely asymptomatic in between typical episodes. This feature of adult CVS was recognized for the first time in theupdatedRomeIVcriteriaforCVS(Table2).Atthepresenttime, theexpertcommitteeendorsestheRomeIVdiagnosticcriteriafor CVS but also acknowledges that the sensitivity and specificity of these criteria have not been subjected to rigorous study. The use of chronic cannabis in CVS has led to a putative new diagnosis of CHS and is discussed in a separate article in this special supplement.
TherearefourphasesofCVS:prodromalphase,vomitingphase, recovery,andasymptomaticorinter-episodicphase. 75 During the prodrome,patientshaveintensenausea,somewithsymptomsofpanic.
Autonomic symptoms such as diarrhea, cold and hot flashes, and profuse sweating may also be present. This is followed by the acute emetic phase where patients will have severe vomiting and retching.
Thevomitingcanoftenberelentlessvaryingfrom1to6times/hour, and the retching often persists even after the stomach has been com- proposed data collection sheet for use in clinic to capture the salient features while entertaining a diagnosis of CVS is shown in Table 3 . ful history focusing on symptoms at the onset of the disorder is important to make an accurate diagnosis, as most patients endorse a discernable cyclic pattern that was part of the initial presentation.
| Investigations
The Rome IV criteria for the diagnosis of CVS require that there is "noorganicpathology"toexplainthesymptoms.Hence,itisreason- Ongoing care with a team to provide support is crucial to achieve good outcomes.
| Treatment of CVS in the emergency department
The present review evaluates the evidence for effectiveness of different drugs used in the acute care setting. The review demonstrates the paucity of Grade I evidence for the effectiveness of any one drug. It is possible that some of these drugs are more effective when used sequentially or in combination. 2, 75, 78 The literature is largely silentontheeffectivenessofsequentialdrugregimens,combinations of drugs, or process improvement implicit in the use of treatment guidelines,ordersets,orexpeditedtreatmentprogramswhichhave provensousefulinthetreatmentofasthma,myocardialinfarction, andstroke. [93] [94] [95] Giventheintrinsicinherentvariationinaclinicallydefinedentity, it is very likely that the response to individual medications will be heterogenousalthoughpossiblethatsingledrugswillworkbestfor awell-definedsubgroup.Itislikelythatacombinationofdrugswill continue to be the preferred approach for the treatment of most of thesepatients.Forthisbroadgroup,acombinationofanti-emetics, analgesics, and sedation are likely to be effective for symptomatic relief of rescue therapy. 96, 97 Discussions with neurologists in the drafting of this review indicated that the improper administration of nasal triptans may account for their seeming ineffectiveness. 66 Allauthorscriticallyreviewedthemanuscript.
R E FE R E N C E S
